Faisal Zain stands at the forefront of healthcare innovation, bringing deep expertise in how medical technology and clinical administration intersect to shape patient outcomes. With a career dedicated to streamlining the manufacturing and implementation of diagnostic and treatment tools, he has a unique vantage point on the friction points within modern clinics. As the 2026 Physician Drug Cost Survey highlights a growing crisis of “hidden” administrative burdens, Zain offers critical insights into how the high cost of prescriptions is transforming the daily operations of medical practices across the United States.
The following discussion explores the intensifying administrative labor required to manage medication affordability, the silent epidemic of patient non-adherence due to financial “sticker shock,” and the specific technological shifts needed to bridge the gap between clinical intent and pharmacy benefit management. We examine the stark reality of how hours spent on paperwork and phone calls are diverting essential resources away from direct patient care and why current reform efforts are meeting such high levels of skepticism among frontline providers.
Many practices handle over thirty prior authorization requests and several hours of step-therapy compliance every week. How is this administrative weight reshaping the daily reality of medical practice?
It has become an exhausting cycle that fundamentally alters how a clinic operates on a minute-to-minute basis. Our recent findings show that 42% of practices are now managing more than 30 prior authorization requests per week, creating a mountain of paperwork that pulls clinicians and staff away from their primary duty of treating patients. This isn’t just a minor annoyance; 72% of physicians are losing at least five hours every single week just trying to navigate these approvals. When you add the fact that 53% of these professionals spend three or more hours specifically on step-therapy compliance, you start to see a picture of a healthcare system that is bogged down by bureaucracy. Two-thirds of physicians now report that they spend at least five hours weekly dealing with cost issues that only arise after the prescription has already been written, leading to a sense of professional burnout and fragmented care.
The revelation that nearly all physicians have had patients stop medications due to cost—often without a single word to their provider—is jarring. What does this disconnect tell us about the current state of drug access and the “sticker shock” patients are facing?
It points to a profound breakdown in the therapeutic relationship fueled by the sheer panic patients feel at the pharmacy counter. It is heartbreaking to see that 96% of physicians have had a patient simply walk away from a necessary treatment because they couldn’t afford it, often without ever reporting that struggle back to the clinic. We are seeing that 42.6% of patients were prescribed a drug in the last 12 months that was simply too expensive for them to fill, creating a gap in care that physicians cannot fix if they are kept in the dark. Even for medications costing less than $250, about 75% of insured consumers reported feeling that initial shock, which suggests that our definitions of “affordability” are wildly out of step with the average person’s financial reality. This silence from patients often means that by the time a physician realizes there is an issue, the patient’s condition may have already worsened significantly, requiring even more intensive and expensive interventions.
With 95% of physicians expressing a willingness to switch to lower-cost alternatives, why do we continue to see such high levels of administrative friction in the prescribing process despite available solutions?
The willingness to help is clearly there, but the tools provided to these doctors are often clunky or arrive too late in the decision-making process to be effective. While 58% of physicians are already proactively offering savings opportunities to their patients, they are often doing so manually without the benefit of integrated, real-time data. Only 33% of physicians believe that recent reform efforts for prior authorization workflows will actually reduce the burden or prevent patient harm, which shows a deep-seated skepticism toward current policy fixes. Nearly half of the doctors surveyed said that if they could just get direct patient benefit data during the initial visit, it would drastically reduce the interruptions they face from pharmacy benefit managers and payer outreach. We must move toward a system that reduces the cognitive burden on the provider by delivering specific cost insights at the moment of the clinical decision, rather than forcing the office to handle five or more patient calls every week regarding prescription costs after the fact.
What is your forecast for the future of prescription cost containment?
I anticipate a shift toward “transparent prescribing” where the financial impact of a drug is as visible as the dosage instructions on the physician’s screen. We will see a greater push for technology that eliminates the “hidden” hours of administrative work, as the current model where 84% of practices receive at least five cost-related patient calls per week is simply unsustainable for a modern business. As physicians demand fewer workflow interruptions, the industry will be forced to provide automated solutions that offer clinically appropriate, lower-cost alternatives before the patient ever leaves the exam room. Ultimately, the success of cost containment will depend on whether we can move the financial conversation away from the pharmacy checkout line and back into the clinic, where the physician can make an informed choice alongside the patient.
